Shares of Colgate-Palmolive (NYSE:CL – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-two analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $105.11.
Several equities analysts have recently weighed in on the stock. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Tuesday. Piper Sandler started coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. Finally, TD Cowen cut their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th.
Check Out Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Stock Up 0.5 %
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.16%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.34% of the company’s stock.
Institutional Investors Weigh In On Colgate-Palmolive
Several large investors have recently bought and sold shares of the stock. Principal Financial Group Inc. increased its position in shares of Colgate-Palmolive by 4.9% in the 3rd quarter. Principal Financial Group Inc. now owns 997,147 shares of the company’s stock valued at $103,514,000 after purchasing an additional 46,944 shares during the last quarter. DGS Capital Management LLC grew its stake in shares of Colgate-Palmolive by 35.9% during the third quarter. DGS Capital Management LLC now owns 8,625 shares of the company’s stock worth $895,000 after purchasing an additional 2,280 shares in the last quarter. Garde Capital Inc. increased its holdings in Colgate-Palmolive by 19.5% in the third quarter. Garde Capital Inc. now owns 1,553 shares of the company’s stock valued at $161,000 after buying an additional 253 shares during the last quarter. Peapack Gladstone Financial Corp raised its stake in Colgate-Palmolive by 2.4% in the third quarter. Peapack Gladstone Financial Corp now owns 50,653 shares of the company’s stock valued at $5,258,000 after buying an additional 1,203 shares in the last quarter. Finally, Tidal Investments LLC lifted its holdings in Colgate-Palmolive by 351.0% during the 3rd quarter. Tidal Investments LLC now owns 284,568 shares of the company’s stock worth $29,541,000 after buying an additional 221,469 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Insider Buying Explained: What Investors Need to Know
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Trading Stocks: RSI and Why it’s Useful
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Energy and Oil Stocks Explained
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.